Nomination period for the Broermann Medical Innovation Award started

17.1.2025 12:17:33 CET | news aktuell GmbH | Press release

Share

Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine
Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields

Gießen, January 17, 2025. The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is aimed at scientists worldwide who have carried out pioneering work in medicine, biotechnology, or related fields with their research.
The nomination portal (www.broermann-award.org/nomination/) is open until March 1, 2025. At one million euros, the prize is more valuable than the Nobel Prize for Medicine, making it one of the most highly endowed awards for medical research worldwide.

The international Broermann Medical Innovation Award recognizes research results that demonstrate a high level of innovation for clinical application and thus have the potential to improve the lives and health of millions of people worldwide. The prize is aimed at scientists whose research has been pioneering in the fields of medicine, biotechnology, or related sciences.

The Broermann Medical Innovation Award was established in 2024 to honor the vision and commitment of Dr. Bernard große Broermann, the founder of the Asklepios Kliniken. The Broermann gemeinnützige GmbH sponsors the award, and the University Hospital Giessen and Marburg (UKGM) manages the organization. “With this award, we want to honor groundbreaking medical discoveries and highlight those whose research brings real improvements in the prevention or treatment of diseases,” says Prof. Werner Seeger, Chairman of the Award Committee. For the Medical Director of the UKGM, Prof. Friedrich Grimminger, the unique prize reflects the clear conviction of the company founder: “Scientific excellence in medicine is always an international team effort, but without the genius of individual researchers, networks are limited in their impact. These key players and drivers of medical innovation should be promoted and recognized worldwide.”

Nomination process and deadlines
Nominations for the Broermann Medical Innovation Award can be submitted until March 1, 2025. The incumbent Hessian Minister President will present the award in December 2025 at the Hessian State Chancellery in Wiesbaden.

Further information on the award, the nomination criteria, and the selection process can be found at www.broermann-award.org. 

For further information, please contact

Broermann Medical Innovation Award
Mirjam Malko
Tel.: +49 (0) 641 / 985-42310
E-Mail: contact@broermann-award.org


Asklepios Kliniken
Corporate Communications and Marketing
Tel.: + 49 (0) 40 / 18 18-82 66 36 
E-Mail: presse@asklepios.com
24-hour on-call service for the press office: +49 (0) 40 / 1818-82 8888

Visit Asklepios on the Internet, Facebook or YouTube:
www.asklepios.com
www.asklepios.com/konzern/gesundheitsmagazin 
www.facebook.com/asklepioskliniken
www.youtube.com/asklepioskliniken 

RHÖN-KLINIKUM AG
Corporate Communications and Marketing
Heike Ochmann
Press Spokeswoman
Tel.: +49 (0) 9771 / 65-12130 
E-Mail: heike.ochmann@rhoen-klinikum-ag.com  

MEDICLIN AG
Dr. Janina Lossen
Press Spokeswoman
Tel:. +49 (0) 781 / 488-180
E-Mail: presse@mediclin.de

UKGM
Frank Steibli
Head of Communications and Press Spokesman 
Tel.: +49 (0) 641 / 985-51020
Mobile: +49 (0) 160 / 7120456
E-Mail: frank.steibli@uk-gm.de 

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Strong international interest in Security Essen and EUDEX24.9.2026 09:14:52 CEST | Press release

From Albania to Uzbekistan – visitors from almost 90 nations Trade visitors from 89 nations to date, international delegations and companies from more than 40 countries: Security Essen and the new Euro Defence Expo (EUDEX) are bringing guests from numerous parts of the world to Messe Essen this week. Visitors from the Netherlands, Belgium, Switzerland, the UK, Poland, the Czech Republic and France are particularly well represented. But experts are also travelling from more distant countries such as Argentina, Ukraine, Singapore and South Korea to network across borders and find out about the latest security and defence technologies. Security Essen focuses on civil security, whilst the inaugural EUDEX is dedicated to the defence industry.

Grünenthal acquires cancer treatment Stivarga®21.9.2026 12:36:25 CEST | Press release

Latest step in Grünenthal’s strategy to acquire established medicines that serve clear medical needs, leverage its commercial and operational capabilities, and drive growth. Stivarga® (regorafenib) is an established oral treatment for certain advanced cancers, including metastatic colorectal cancer, gastrointestinal stromal tumours (GIST) and hepatocellular carcinoma (liver cancer). It is approved and available in more than 90 markets worldwide. Grünenthal has invested around €2.6 billion in successful M&A transactions since 2017, significantly strengthening its profitability and further funding its innovative research pipeline.

S&Ds to von der Leyen: Europe must deliver for people and strengthen its sovereignty16.9.2026 09:22:05 CEST | Press release

Strasbourg, 15 september 2026 Ahead of Commission President Ursula von der Leyen’s State of the Union address and debate in Strasbourg on September 16, 2026, the Socialists and Democrats in the European Parliament (S&D) call for a change of direction: away from deregulation and towards better living and working conditions for Europeans, tangible social justice, and a stronger, more sovereign Europe. Iratxe García Pérez, president of the S&D Group in the European Parliament, said: “Europe is facing a choice. Not simply between different policies or political parties, but between two very different visions of our future. One vision is built on fear, power without limits, nationalism and the rule of the strongest. The other vision is the Europe we believe in: a Europe that protects its people, defends democracy and international law, fights climate change, guarantees social rights and has the strength to decide its own future.”* A Europe that delivers for its people The S&D Group has deli

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye